Your browser doesn't support javascript.
loading
Impact of the first COVID-19 lockdown in Germany on the rate of acute infections during intensive chemotherapy for Hodgkin lymphoma.
Jacob, Anne Sophie; Kaul, Helen; Fuchs, Michael; Gillessen, Sarah; Kreissl, Stefanie; Pluetschow, Annette; Momotow, Jesko; Schaub, Valdete; Huettmann, Andreas; Haenel, Mathias; Zimmermann, Andreas; Dierlamm, Judith; Meissner, Julia; Mathas, Stephan; Martin, Sonja; Engert, Andreas; Hallek, Michael; Borchmann, Peter; Lehmann, Clara.
Affiliation
  • Jacob AS; Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, Faculty of Medicine and University Hospital Cologne, Kerpener Str. 62, 50937, Cologne, Germany.
  • Kaul H; German Hodgkin Study Group (GHSG), University of Cologne, Cologne, Germany.
  • Fuchs M; Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, Faculty of Medicine and University Hospital Cologne, Kerpener Str. 62, 50937, Cologne, Germany.
  • Gillessen S; German Hodgkin Study Group (GHSG), University of Cologne, Cologne, Germany.
  • Kreissl S; Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, Faculty of Medicine and University Hospital Cologne, Kerpener Str. 62, 50937, Cologne, Germany.
  • Pluetschow A; German Hodgkin Study Group (GHSG), University of Cologne, Cologne, Germany.
  • Momotow J; Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, Faculty of Medicine and University Hospital Cologne, Kerpener Str. 62, 50937, Cologne, Germany.
  • Schaub V; German Hodgkin Study Group (GHSG), University of Cologne, Cologne, Germany.
  • Huettmann A; Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, Faculty of Medicine and University Hospital Cologne, Kerpener Str. 62, 50937, Cologne, Germany.
  • Haenel M; German Hodgkin Study Group (GHSG), University of Cologne, Cologne, Germany.
  • Zimmermann A; Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, Faculty of Medicine and University Hospital Cologne, Kerpener Str. 62, 50937, Cologne, Germany.
  • Dierlamm J; German Hodgkin Study Group (GHSG), University of Cologne, Cologne, Germany.
  • Meissner J; Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, Faculty of Medicine and University Hospital Cologne, Kerpener Str. 62, 50937, Cologne, Germany.
  • Mathas S; German Hodgkin Study Group (GHSG), University of Cologne, Cologne, Germany.
  • Martin S; Eberhard-Karls-Universität-Universitätsklinik Tübingen, Inneren Medizin II, Tübingen, Germany.
  • Engert A; Universitätsklinik Essen, Klinik Für Hämatologie/WTZ Ambulanz, Essen, Germany.
  • Hallek M; Klinikum Chemnitz, Krankenhaus Küchwald, Klinik Für Innere Medizin III/Studiensekretariat, Chemnitz, Germany.
  • Borchmann P; Medizinische Klinik Und Poliklinik III, Klinikum Der Universität München, LMU München, Munich, Germany.
  • Lehmann C; Abt. Hämatologie/Onkologie, Onkologisches Zentrum, Universitätsklinikum Hamburg-Eppendorf, Hamburg, Germany.
Infection ; 50(4): 925-932, 2022 Aug.
Article in En | MEDLINE | ID: mdl-35182355

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Hodgkin Disease / COVID-19 / Infections Type of study: Prognostic_studies Limits: Adult / Humans Language: En Journal: Infection Year: 2022 Document type: Article Affiliation country: Germany Country of publication: Germany

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Hodgkin Disease / COVID-19 / Infections Type of study: Prognostic_studies Limits: Adult / Humans Language: En Journal: Infection Year: 2022 Document type: Article Affiliation country: Germany Country of publication: Germany